| Document |
Document Title |
|
WO/2007/090295A1 |
This application relates to metal-containing coordination polymers having high birefringent values. For example, polymers having birefringent values within the range of 0.07 to 0.45 are described. The polymers may comprise units having t...
|
|
WO/2007/091713A1 |
Disclosed is a polynuclear complex containing, in a molecule, a plurality of metal atoms and one or more ligands L satisfying the following conditions (i), (ii) and (iii). (i) It has a group having a polymerization-reactive multiple bond...
|
|
WO/2007/091616A1 |
A polynuclear metal complex having in each molecule not only at least one large cyclic ligand having 5 to 15 coordinating atoms but also multiple metal atoms is subjected to any of heating treatment, radiation exposure treatment and elec...
|
|
WO/2007/083395A1 |
A bisphosphonoamine compound represented by the following formula (I): wherein R1, R2, R3, R4 and R5 are independently an alkyl group having 1 to 6 carbon atoms, and n is an integer of 1 to 6, is extremely useful as an intermediate for p...
|
|
WO/2007/079858A1 |
Transition metal complexes with a ligand of formula (I), where n1, n2 and n3 independently = 1 or 2 are used as catalytically effective activators for peroxy compounds in cleaning solutions for hard surfaces in particular for dish washin...
|
|
WO/2007/073472A2 |
The present invention relates to a compound for use as a chelator in the radioactive labeling of biomolecules with metal tricarbonyl complexes, which compound has the general Formula (I) wherein M is a monovalent cation, such as Li, Na, ...
|
|
WO/2007/001940A3 |
The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled wit...
|
|
WO/2007/001958A3 |
The radiolabeled non-natural amino acid 1-amino-3- cyclobutane-1-carboxylic acid (ACBC) and its analogs are candidate tumor imaging agents useful for positron emission tomography and single photon emission computed tomography due to thei...
|
|
WO/2006/120133A3 |
The present invention concerns coloring keratin fibers, especially human hair, with colored metal complexes.
|
|
WO/2007/012377A3 |
The invention relates to methods for the treatment of cells with electric fields in order to modify the membrane permeability of said cells with the aid of lipophilic ions as a medium additive. The invention more particularly relates to ...
|
|
WO/2007/031773A1 |
An organic light-emitting device comprising: an anode; a cathode; a light-emitting layer located between the anode and the cathode, said light-emitting layer containing a light-emitting metal complex comprising general formula (1) where ...
|
|
WO/2007/012377A2 |
The invention relates to methods for the treatment of cells with electric fields in order to modify the membrane permeability of said cells with the aid of lipophilic ions as a medium additive. The invention more particularly relates to ...
|
|
WO/2007/001940A2 |
The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled wit...
|
|
WO/2007/001958A2 |
The radiolabeled non-natural amino acid 1-amino-3- cyclobutane-1-carboxylic acid (ACBC) and its analogs are candidate tumor imaging agents useful for positron emission tomography and single photon emission computed tomography due to thei...
|
|
WO/2006/136564A1 |
Compounds of general formula (I): in which: R1, R2, R3, R4, R5 and FG are as defined in the specification and claims, optionally conjugated with a suitable molecule able to interact with physiological systems; and their chelates with bi-...
|
|
WO/2006/120133A2 |
The present invention concerns coloring keratin fibers, especially human hair, with colored metal complexes.
|
|
WO2005117907A3 |
Chiral ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes according to the present invention are useful as catalysts in asymmetric reactions, such as, hydrogenation,...
|
|
WO/2006/080993A1 |
This invention relates to novel cationic crown-ether containing metal complexes, methods of preparing the cationic crown-ether containing metal complexes, and radiopharmaceutical compositions comprising the cationic crown-ether containin...
|
|
WO2006032780A8 |
The invention concerns compounds of formula (I) and their use as catalyst.
|
|
WO2006037988A3 |
Novel radioactive technetium and rhenium complexes comprising tripodal ligands are provided by the present invention. In particular, Tc(I) complexes are provided by the present invention. Novel ligands suitable for the formation of the t...
|
|
WO/2006/054466A1 |
A radioactive technetium complex that realizes enhancing of in a single photon discharge type tomogram, cardiac contrast and initial circulation extraction ratio; and a radioactive imaging diagnostic agent comprising the complex. The com...
|
|
WO2005068074A3 |
The invention accordingly relates to the use as catalysts of at least one metal complex of formula (1) [LnMemXp]2Yq (1), wherein L is a ligand of formula (2) wherein Q1 is N or CR 10, Q2 is N or CR11, and wherein the remaining substituen...
|
|
WO/2006/043110A1 |
Complex salts, based on ionic liquids, which exhibit at least one light emitting property selected from (a) fluorescence, (b) phosphorescence, and (c) electroluminescence when in the solid state; and which have a melting point below 250°C.
|
|
WO/2006/041056A1 |
Disclosed is a metal-containing coordination compound represented by the formula (1) below and having characteristics equivalent to or better than those of metal complexes which can be polymerized or dissolved in a solvent. Also disclose...
|
|
WO/2006/037988A2 |
Novel radioactive technetium and rhenium complexes comprising tripodal ligands are provided by the present invention. In particular, Tc(I) complexes are provided by the present invention. Novel ligands suitable for the formation of the t...
|
|
WO/2006/032780A1 |
The invention concerns compounds of formula (I) and their use as catalyst.
|
|
WO/2006/026855A1 |
The invention provides a method for manufacturing or preparing neutral, low molecular weight 99mTc-labeled and 186Re-labeled carbohydrate complexes with an improved radiochemical yield from a simple functionalized sugar, such as glucosam...
|
|
WO/2006/024493A1 |
The invention relates to a novel method for producing organorhenium(VII) oxides
|
|
WO/2006/015414A1 |
The present invention provides an IR-absorbing naphthalocyanine dye of formula (I): wherein M is selected from Si(A1)(A2), Ge(A1)(A2), Ga(A1), Mg, Al(A1), TiO, Ti(A1)(A2), ZrO, Zr(A1)(A2), VO, V(A1)(A2), Mn, Mn(A1), Fe, Fe(A1), Co, Ni, C...
|
|
WO2005097123A3 |
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive...
|
|
WO2005097808A3 |
Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes, can be utilized in a number of applications, for example, as proton conductors in electrochemical devices. The presence of encapsulated metal atoms, preferabl...
|
|
WO2005077962A3 |
Compositions containing crowned dithiocarbamate metal complexes and methods of using these compositions; neutral and cationic radioactive metal-nitrido complexes of crowned dithiocarbamates (DTCs) and methods of using these complexes as ...
|
|
WO/2005/117907A2 |
Chiral ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes according to the present invention are useful as catalysts in asymmetric reactions, such as, hydrogenation,...
|
|
WO/2005/116039A1 |
The present invention provides a novel class of molecular coordination compounds, and more particularly, square supramolecular metal coordination grids of the formula (I): [Ma2(L)2a]Xz (I), wherein M is a transition metal: a is 3, 4, 5 o...
|
|
WO/2005/108330A1 |
The aim of the invention is to provide radiolytically and metabolically stable metal complexes, which are suitable for conjugation with biomolecules and to provide a method for their production. This is achieved by metal complexes based ...
|
|
WO/2005/105303A1 |
The present invention relates to the use of certain manganese complexes having bispyridylpyrimidine or bispyridyltriazine ligands or mixtures of such ligands as catalysts for reactions with peroxy compounds for bleaching coloured stains ...
|
|
WO/2005/097808A2 |
Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes, can be utilized in a number of applications, for example, as proton conductors in electrochemical devices. The presence of encapsulated metal atoms, preferabl...
|
|
WO/2005/097123A2 |
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive...
|
|
WO/2005/090371A1 |
A transition metal complex which is a bis-arylimine pyridine MXn complex, comprising a bis-arylimine pyridine ligand having the formula (I), wherein R1-R5, R7-R9, R12 and R14 are each, independently, hydrogen, optionally substituted hydr...
|
|
WO/2005/087697A1 |
[PROBLEMS] To provide a metal complex capable of being suitably used for manufacturing a metal-containing thin film by the CVD method and a method for manufacturing a metal-containing thin film. [MEANS FOR SOLVING PROBLEMS] A metal compl...
|
|
WO/2005/082894A1 |
The present invention relates to cell targeting conjugates and in particular, but not exclusively, to methods of their use in selectively eliminating and in selectively imaging target cells. The invention also relates to processes for pr...
|
|
WO2005067388A3 |
The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention fur...
|
|
WO/2005/079865A1 |
One aspect of the invention relates to complexes of a radionuclide with various heteroaryl ligands, e.g., imidazolyl and pyridyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeutic applicat...
|
|
WO/2005/079866A1 |
One aspect of the invention relates to complexes of technetium (Tc) and rhenium (Re) with various heteroaromatic ligands, e.g., quinolinyl and isoquinolinyl ligands, and their use in fluoresence and radioimaging for a variety of clinical...
|
|
WO/2005/077962A2 |
Compositions containing crowned dithiocarbamate metal complexes and methods of using these compositions; neutral and cationic radioactive metal-nitrido complexes of crowned dithiocarbamates (DTCs) and methods of using these complexes as ...
|
|
WO/2005/067388A2 |
The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention fur...
|
|
WO/2005/068074A2 |
The invention accordingly relates to the use as catalysts of at least one metal complex of formula (1) [LnMemXp]2Yq (1), wherein L is a ligand of formula (2) wherein Q1 is N or CR 10, Q2 is N or CR11, and wherein the remaining substituen...
|
|
WO2005033119A9 |
The application discloses the use of supramolecular compounds as antitumour, antimicrobial (such as antibacterial and antiprotozoal) and antiviral agents. Such compounds comprise ligands as defined in the application coordinated to at le...
|
|
WO2004043380A8 |
The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment, the invention relates the metho...
|
|
WO/2005/044149A1 |
The present invention relates to hyaluronic acid polymers modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. The invention further provides pharmaceutical compositions co...
|
